Funding news for global health researchers December 6, 2021

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Top NIH Funding News

NIH funding news that may be relevant to global health researchers.

• Request for Information on Proposed Updates and Long-Term Considerations for the NIH Genomic Data Sharing Policy (NOT-OD-22-029)
• Pre-Application Webinar for NCI's Innovative Molecular Analysis Technologies (IMAT) Innovative Technologies Funding Opportunities (RFA-CA-22-001, RFA-CA-22-003) (NOT-CA-22-022)

Upcoming Deadlines for Fogarty Funding Opportunities

• HIV-associated Noncommunicable Diseases Research at Low- and Middle-Income Country Institutions
  Application deadline: December 8, 2021
• Global Brain Disorders Research
  Application deadline: December 9, 2021
• Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (R01 – Clinical Trial Optional)
  Application deadline: December 20, 2021
• International Research Scientist Development Award (IRSDA)
  Application deadline: March 9, 2022
• Upcoming deadlines for all Fogarty funding opportunities

Funding Opportunities

NIH funding opportunities for which foreign organizations may apply.

• Drug Discovery for Nervous System Disorders (R01 Clinical Trials Not Allowed)  (PAR-22-031)
  Application Receipt Dates: Multiple dates, see announcement.
• Drug Discovery for Nervous System Disorders (R21 Clinical Trials Not Allowed) (PAR-22-032)
  Application Receipt Date(s): January 7, 2025
• Resource Networks for Protein Polymorphisms in Alzheimer’s Disease and its Related Dementias (AD/ADRD) (U24 Clinical Trial Not Allowed) (RFA-AG-22-030)
  Application Receipt Date(s): January 10, 2022

Other Funding News

NIH Notices of Special Interest (NOSIs) related to opportunities on which Fogarty is a funding partner.

• Availability of Administrative Supplements for Helping to End Addiction Long-term (HEAL) Initiative awardees to make data Findable, Accessible, Interoperable, and Reusable (FAIR) through the HEAL Data Ecosystem (NOT-OD-22-033)
  Expiration Date: January 19, 2022
• Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp Clinical Trial Optional) ) (NOT-OD-22-032)
  Expiration Date: February 1, 2024
• KC Donnelly Externship (Admin Supp Clinical Trial Not Allowed) (NOT-ES-22-003)
  Expiration Date: February 29, 2024
• Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) (NOT-OD-22-031)
  Expiration Date: February 29, 2024
• Administrative Supplements and Urgent Competitive Revisions on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA (NOT-AA-22-002)
  Expiration Date: May 8, 2024

NIH Notices of Special Interest (NOSIs) that may be of interest to global health researchers.

• RNA Modifications in Cancer Biology (NOT-CA-22-003)
  Expiration Date: May 8, 2023
• Molecular and Genetic Characterization of Inborn Errors of Immunity (NOT-AI-21-082)
  Expiration Date: Janury 8, 2025
• Accelerating Malaria Vaccine Discovery (NOT-AI-22-014)
  Expiration Date: January 8, 2025
• Research in the Chemistry and Pharmacology of Addictive Drugs (NOT-DA-23-002)
  Expiration Date: May 8, 2025

Notices of intent to publish NIH funding opportunities for which foreign organizations may apply.

• BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Comprehensive Centers for Human and Non-Human Primate Brain (UM1 Clinical Trial Not Allowed) (NOT-NS-22-045)
• BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Comprehensive Centers for Mouse Brain (UM1 Clinical Trial Not Allowed) (NOT-NS-22-046)